Interferon-alpha 2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism

Citation
F. Romerio et al., Interferon-alpha 2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism, BR J CANC, 83(4), 2000, pp. 532-538
Citations number
39
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
BRITISH JOURNAL OF CANCER
ISSN journal
00070920 → ACNP
Volume
83
Issue
4
Year of publication
2000
Pages
532 - 538
Database
ISI
SICI code
0007-0920(200008)83:4<532:I2RPAA>2.0.ZU;2-C
Abstract
Interferon (IFN)-alpha affects the growth, differentiation and function of various cell types by transducing regulatory signals through the Janus tyro sine kinase/signal transducers of activation and transcription (Jak/STAT) p athway. The signalling pathways employing the mitogen-activated ERK-activat ing kinase (MEK) and the extracellular-regulated kinase (ERK) are critical in growth factors signalling. Engagement of the receptors, and subsequent s timulation of Ras and Raf, initiates a phosphorylative cascade leading to a ctivation of several proteins among which MEK and ERK play a central role i n routing signals critical in controlling cell development, activation and proliferation. We demonstrate here that 24-48 h following treatment of tran sformed T- and monocytoid cell lines with recombinant human IFN-alpha 2b bo th the phosphorylation and activity of MEK1 and its substrates ERK1/2 were reduced. In contrast, the activities of the upstream molecules Ras and Raf- l were not affected. No effect on MEK/ERK activity was observed upon short- term exposure (1-30 min) to IFN. The anti-proliferative effect of IFN-alpha was increased by the addition in the culture medium of a specific inhibito r of MEK, namely PD98059. In conclusion, our results indicate that IFN-alph a regulates the activity of the MEK/ERK pathway and consequently modulates cellular proliferation through a Ras/Raf-independent mechanism. Targeting t he MEK/ERK pathway may strengthen the IFN-mediated anti-cancer effect. (C) 2000 Cancer Research Campaign.